Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases
Sudha R Raman1, Kenneth K C Man2,3,4,5,6, Shahram Bahmanyar7,8, Anick Berard9, Scott Bilder10, Takoua Boukhris9, Greta Bushnell11, Stephen Crystal10, Kari Furu12, Yea-Huei KaoYang13, Øystein Karlstad12, Helle Kieler7, Kiyoshi Kubota14, Edward Chia-Cheng Lai13,15, Jaana E Martikainen16, Géric Maura17, Nicholas Moore18, Dolores Montero19, Hidefumi Nakamura20, Anke Neumann17
1Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
2Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
3Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
4Research Department of Policy and Practice, University College London School of Pharmacy, London, UK
5Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands
6Department of Social Work and Social Administration, Faculty of Social Science, The University of Hong Kong, Hong Kong, China
7Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
8Centre for Psychiatry Research, Karolinska Institutet and Stockholm Health Care Services, Stockholm, Sweden
9Faculty of Pharmacy, University of Montreal, and CHU Ste-Justine Research Center, Montreal, Quebec, Canada
10Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA
11Department of Epidemiology, University of North Carolina, Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC, USA
12Division of Mental and Physical Health, Norwegian Institute of Public Health, Oslo, Norway
13School of Pharmacy and Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan
14Drug Safety Research Unit, Tokyo, Japan
15Department of Pharmacy, National Cheng Kung University Hospital, Tainan, Taiwan
16Research Unit, Social Insurance Institution, Helsinki, Finland
17Department of Studies in Public Health, French National Health Insurance, Paris, France
18Bordeaux PharmacoEpi, Inserm CIC1401, Université de Bordeaux, Bordeaux, France
19Spanish Agency for Medicines and Medical Devices, Madrid, Spain
20Clinical Research Center, National Center for Child Health and Development, Tokyo, Japan
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
The Lancet Psychiatry
Tập 5
824-835
Thông tin tác giả